Douglas G. Cole Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas G. Cole.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas G. Cole. Douglas G. Cole is a Director in AVEO PHARMACEUTICALS INC ($AVEO) and a Director in AGIOS PHARMACEUTICALS INC ($AGIO) and a Director in Quanterix Corp ($QTRX) and a Director in Editas Medicine, Inc. ($EDIT) and a Director in Denali Therapeutics Inc. ($DNLI) and a Director in Sana Biotechnology, Inc. ($SANA).
Address: C/O AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which Douglas G. Cole is an Insider
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas G. Cole: Director
Holdings: 2,778 shares
Current Value: $123,399
Latest Transaction: Aug 11 2016
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVEO PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas G. Cole: Director
Holdings: 395,565 shares
Current Value: $241,295
Latest Transaction: May 16 2011
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Denali Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Douglas G. Cole: Director
Holdings: 5,327 shares
Latest Transaction: Jun 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Douglas G. Cole: Director
Holdings: 3,171 shares
Current Value: $58,854
Latest Transaction: Aug 21 2017
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Quanterix Corp
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Douglas G. Cole: Director
Holdings: 2,270 shares
Latest Transaction: Aug 09 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sana Biotechnology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Douglas G. Cole: Director
Holdings: 0 shares
Latest Transaction: Feb 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Douglas G. Cole
Sentiment: All, AGIO, AVEO, DNLI, EDIT, QTRX, SANA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 63.76 | 6,222 | 396,715 | 6,222 | |
| Jun 04 2021 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Grant | A | 0.00 | 2,074 | 0 | 5,327 | 3.3 K to 5.3 K (+63.76 %) |
| Feb 05 2021 | SANA | Sana Biotechnology ... | Cole Douglas G. | Director | Option Exercise | A | 25.00 | 14,000 | 350,000 | 14,000 | |
| Jun 05 2020 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
| Jun 05 2020 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
| May 31 2019 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
| Aug 09 2018 | QTRX | Quanterix Corp | Cole Douglas G. | Director | Option Exercise | A | 14.80 | 7,900 | 116,920 | 7,900 |